You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CTL019

Showing 1 - 25 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Worldwide (CTL019)

Completed
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Tisagenlecleucel
  • Lymphodepleting chemotherapy
  • San Francisco, California
  • +25 more
Jan 27, 2023

Lymphoma, B-Cell Trial in Philadelphia (CD19 redirected autologous T cells (CTL019 or CTL119 cells))

Not yet recruiting
  • Lymphoma, B-Cell
  • CD19 redirected autologous T cells (CTL019 or CTL119 cells)
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Mar 18, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (CTL019)

Active, not recruiting
Has Results
  • B-cell Acute Lymphoblastic Leukemia
  • CTL019
  • Los Angeles, California
  • +24 more
Jun 23, 2022

Follicular Lymphoma (FL) Trial (biological, drug, other)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Tisagenlecleucel
  • +4 more
  • (no location specified)
May 24, 2023

Non Hodgkin Lymphoma Trial in Cologne, Essen (CTL019)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • CTL019
  • Cologne, Germany
  • +1 more
Mar 2, 2022

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program Trial in Worldwide

Recruiting
  • Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
  • Previously treated CAR-T patients
  • Phoenix, Arizona
  • +71 more
Nov 14, 2022

DLBCL (DLBCL) Trial (Tisagenlecleucel)

Withdrawn
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Tisagenlecleucel
  • (no location specified)
Feb 25, 2022

B-cell Acute Lymphoblastic Leukemia Trial (Tisagenlecleucel)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Tisagenlecleucel
  • (no location specified)
Feb 3, 2022

Acute Lymphoblastic Leukemia Trial in Worldwide (CTL019)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • CTL019
  • Wien, Austria
  • +10 more
Jun 30, 2021

Follicular Lymphoma Trial in Worldwide (tisagenlecleucel)

Active, not recruiting
Has Results
  • Follicular Lymphoma
  • tisagenlecleucel
  • Duarte, California
  • +29 more
Nov 2, 2022

DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +6 more
  • Axicabtagene Ciloleucel
  • +10 more
  • (no location specified)
Jan 13, 2023

B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia, Refractory B-cell Acute Lymphoblastic

Completed
Has Results
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CTL019 T-cells
  • Los Angeles, California
  • +12 more
Oct 29, 2020

B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma Trial in Canada, Japan (CTL019)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Diffuse Large B-cell Lymphoma
  • CTL019
  • Hamilton, Ontario, Canada
  • +41 more
Oct 17, 2022

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Diffuse Large B-cell Lymphoma; Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Diffuse Large B-cell Lymphoma; Acute Lymphoblastic Leukemia
  • YTB323 and ibrutinib
  • YTB323 single agent
  • Tampa, Florida
  • +20 more
Feb 24, 2022

Acute Lymphoblastic Leukemia Trial (Tisagenlecleucel, Blinatumomab, Inotuzumab)

Withdrawn
  • Acute Lymphoblastic Leukemia
  • Tisagenlecleucel
  • +2 more
  • (no location specified)
Jul 7, 2020

Lymphoblastic Leukemia, Acute, Childhood Trial in Philadelphia (Tocilizumab, CART 19)

Completed
  • Lymphoblastic Leukemia, Acute, Childhood
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 30, 2021

Clinical Presentation of Genetic Disorders in Patients Attending

Not yet recruiting
  • Genetic Disease Clinical Presentation in Patients Attending Genetics Outpatient Clinic of Assiut University Children Hospital
    • (no location specified)
    Jun 2, 2023

    Diffuse Large B-cell Lymphoma Trial in Tampa, Philadelphia (Tisagenlecleucel, Ibrutinib)

    Terminated
    • Diffuse Large B-cell Lymphoma
    • Tampa, Florida
    • +1 more
    Jan 27, 2023

    Relapsed or Refractory B-cell Lymphoma Trial in Guangzhou (infusion of JY231 injection)

    Recruiting
    • Relapsed or Refractory B-cell Lymphoma
    • infusion of JY231 injection
    • Guangzhou, Guangdong, China
      Guangdong Second Provincial General Hospital
    Sep 17, 2023

    Non-Hodgkin Lymphoma Trial in Worldwide (Tisagenlecleucel after optional bridging and lymphodepleting chemo, Platinum-based

    Active, not recruiting
    • Non-Hodgkin Lymphoma
    • Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy
    • Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and autologous hematopoietic stem cell transplant (HSCT)
    • La Jolla, California
    • +66 more
    Jan 6, 2023

    Musculoskeletal Diseases or Conditions Trial (Educational Tool)

    Not yet recruiting
    • Musculoskeletal Diseases or Conditions
    • Educational Tool
    • (no location specified)
    Jun 19, 2023

    HIV Trial in Rochester (HIV p17/p24:Ty-VLP, Aluminum hydroxide)

    Completed
    • HIV Infections
    • HIV p17/p24:Ty-VLP
    • Aluminum hydroxide
    • Rochester, New York
      Univ. of Rochester AVEG
    Oct 28, 2021

    Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

    Recruiting
    • Chronic Granulomatous Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 23, 2022

    CD19+ Diffuse Large B-cell Lymphomas, Follicular Lymphomas, Mantle Cell Lymphomas Trial in Philadelphia (Pembrolizumab)

    Completed
    Has Results
    • CD19+ Diffuse Large B-cell Lymphomas
    • +2 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jul 20, 2021

    Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

    Recruiting
    • Hematopoietic Malignancy
    • +2 more
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Nov 6, 2023